Who invested in Avrobio?
Avrobio's investors include Atlas Venture, Morningside Group, Cormorant Asset Management, Atlas and Brace Pharma, and 5 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$85Mraised across 2 rounds since 2016, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $60M sold, first sale Jan 2018
Reported by BusinesswireSEC filing: $7.5M sold, first sale Jul 2016
From the SEC filings it signed: 5 on the team.
On the board, as filediBruce BoothChristopher PaigeIan ClarkJoshua ResnickScott Requadt
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Avrobio's investors include Atlas Venture, Morningside Group, Cormorant Asset Management, Atlas and Brace Pharma, and 5 more on record.
Avrobio has raised $85M across 2 rounds since 2016.
Avrobio's most recent round was an Undisclosed round of $60M in Feb 2018.
Its most recent round, $60M in Feb 2018, is also its largest on record.
Avrobio's first round on record, in Aug 2016, was backed by Atlas Venture and Clarus & Life Sciences.
Avrobio's latest named round is an Undisclosed round, in Feb 2018.
Avrobio is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.